Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04194528 · ClinicalTrials.gov registry record · NA
S1916 Digital Medicine Program for Pain Control in Cancer Patients
A NA study, sponsored by SWOG Cancer Research Network.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT04194528: Clinical Trial NA study, sponsored by SWOG Cancer Research Network.
NCT04194528 is a NA study that was terminated before completion, run by SWOG Cancer Research Network. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04194528, a NA study, was terminated before completion, sponsored by SWOG Cancer Research Network.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
This is a feasibility study to assess the use of a Digital Medicine Program (consisting of an FDA-approved ingestible sensor co-encapsulated with oxycodone/acetaminophen (5 mg/325 mg), a small wearable patch, and a mobile application) in cancer patients with metastatic disease experiencing uncontrolled pain.
Primary Outcome
Feasibility will be determined by accrual (as confirmed by registration to the trial), adherence and patient retention (as measured and relayed by the wearable patch/sensor).
Interventions
- DRUG Oxycodone/acetaminophen 5/325 mg
- DEVICE Proteus digital medicine program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2020-01-22 |
| Est. Completion | 2020-09-16 |
| Phase | NA |
Why NCT04194528 stopped before completion
NCT04194528 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Oxycodone/acetaminophen 5/325 mg is the first listed.
NCT04194528 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04194528 about?
NCT04194528 is a clinical study titled "S1916 Digital Medicine Program for Pain Control in Cancer Patients". This is a feasibility study to assess the use of a Digital Medicine Program (consisting of an FDA-approved ingestible sensor co-encapsulated with oxycodone/acetaminophen (5 mg/325 mg), a small wearable patch, and a mobile application) in cancer patients with metastatic disease experiencing uncontrol...
What is the current status of trial NCT04194528?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2020-01-22. Estimated completion is 2020-09-16.
What interventions are being tested in trial NCT04194528?
The interventions under investigation include: Oxycodone/acetaminophen 5/325 mg (DRUG), Proteus digital medicine program (DEVICE).
Who is sponsoring clinical trial NCT04194528?
This trial is sponsored by SWOG Cancer Research Network, which has 270 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04194528's enrollment target sits among peer trials
2 1997th of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI